194 related articles for article (PubMed ID: 17336444)
21. [Genetic information under control--role of eukaryotic topoisomerase I].
Derlacz RA
Postepy Biochem; 2001; 47(3):243-52. PubMed ID: 11908093
[No Abstract] [Full Text] [Related]
22. Human topoisomerase I forms double cleavage complexes on natural DNA.
Søe K; Hartung S; Grosse F
Biochem Biophys Res Commun; 2006 Oct; 349(1):178-85. PubMed ID: 16930551
[TBL] [Abstract][Full Text] [Related]
23. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities.
Stewart AF; Herrera RE; Nordheim A
Cell; 1990 Jan; 60(1):141-9. PubMed ID: 2153054
[TBL] [Abstract][Full Text] [Related]
24. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
Garg LC; DiAngelo S; Jacob ST
Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639
[TBL] [Abstract][Full Text] [Related]
25. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
[TBL] [Abstract][Full Text] [Related]
26. Cross-talks between transcription and post-transcriptional events within a 'mRNA factory'.
Hagiwara M; Nojima T
J Biochem; 2007 Jul; 142(1):11-5. PubMed ID: 17567655
[TBL] [Abstract][Full Text] [Related]
27. Site-specific in vivo cleavages by DNA topoisomerase I in the regulatory regions of the 35 S rRNA in Saccharomyces cerevisiae are transcription independent.
Vogelauer M; Camilloni G
J Mol Biol; 1999 Oct; 293(1):19-28. PubMed ID: 10512712
[TBL] [Abstract][Full Text] [Related]
28. DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus.
Baranello L; Bertozzi D; Fogli MV; Pommier Y; Capranico G
Nucleic Acids Res; 2010 Jan; 38(1):159-71. PubMed ID: 19854946
[TBL] [Abstract][Full Text] [Related]
29. On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex.
Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
Bioorg Med Chem; 2005 Feb; 13(4):1381-6. PubMed ID: 15670945
[TBL] [Abstract][Full Text] [Related]
30. Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.
Rahier NJ; Eisenhauer BM; Gao R; Jones SH; Hecht SM
Org Lett; 2004 Feb; 6(3):321-4. PubMed ID: 14748583
[TBL] [Abstract][Full Text] [Related]
31. Pausing sites of RNA polymerase II on actively transcribed genes are enriched in DNA double-stranded breaks.
Singh S; Szlachta K; Manukyan A; Raimer HM; Dinda M; Bekiranov S; Wang YH
J Biol Chem; 2020 Mar; 295(12):3990-4000. PubMed ID: 32029477
[TBL] [Abstract][Full Text] [Related]
32. Injection of anti-topoisomerase I IgG into nuclei of mouse L929 cells leads to inhibition of transcription of exogenously introduced SV40 large T antigen gene.
Matsumoto K; Sugawara I; Takahashi T; Andoh T
Exp Cell Res; 1993 Jan; 204(1):6-10. PubMed ID: 8380142
[TBL] [Abstract][Full Text] [Related]
33. Antitumour drugs impede DNA uncoiling by topoisomerase I.
Koster DA; Palle K; Bot ES; Bjornsti MA; Dekker NH
Nature; 2007 Jul; 448(7150):213-7. PubMed ID: 17589503
[TBL] [Abstract][Full Text] [Related]
34. Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.
Castelli S; Campagna A; Vassallo O; Tesauro C; Fiorani P; Tagliatesta P; Oteri F; Falconi M; Majumder HK; Desideri A
Arch Biochem Biophys; 2009 Jun; 486(2):103-10. PubMed ID: 19397888
[TBL] [Abstract][Full Text] [Related]
35. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.
Desai SD; Zhang H; Rodriguez-Bauman A; Yang JM; Wu X; Gounder MK; Rubin EH; Liu LF
Mol Cell Biol; 2003 Apr; 23(7):2341-50. PubMed ID: 12640119
[TBL] [Abstract][Full Text] [Related]
36. Identification of a minimal functional linker in human topoisomerase I by domain swapping with Cre recombinase.
Frøhlich RF; Juul S; Nielsen MB; Vinther M; Veigaard C; Hede MS; Andersen FF
Biochemistry; 2008 Jul; 47(27):7127-36. PubMed ID: 18553933
[TBL] [Abstract][Full Text] [Related]
37. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene.
Stewart AF; Schütz G
Cell; 1987 Sep; 50(7):1109-17. PubMed ID: 2887294
[TBL] [Abstract][Full Text] [Related]
38. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
39. Splicing, transcription, and chromatin: a ménage à trois.
Allemand E; Batsché E; Muchardt C
Curr Opin Genet Dev; 2008 Apr; 18(2):145-51. PubMed ID: 18372167
[TBL] [Abstract][Full Text] [Related]
40. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
